Mechanism of Action of Various Psychotropic Agents on Monoaminergic Receptors and Transmembrane signal Control.
各种精神药物对单胺能受体的作用机制和跨膜信号控制。
基本信息
- 批准号:60570490
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1985
- 资助国家:日本
- 起止时间:1985 至 1986
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The metabolism of inositol phospholipids in response to 5HT was investigated in human platelets using the sensitive radioisotopicmethod of Berridge (1983), since it is well-known that ketanserin antagonizes 5HT-induced shape change and rise of intracellular free Ca ion. In platelets prelabeled with <^3H> -myo inositol, in Ca ion free HEPES buffer containing 10mM Licl and l <micro> M fluoxetine, 5HT caused a dose-dependent accumulation of inositol-l-phosphate(IP-l) during 15 min incubation. A maximal increase in IP-l formation was observed at 30 <micro> M of 5HT and its <EC_(50)> value was 4 <micro> M. Ketanserin, a selective 5HT-2 antagonist, was a potent inhibitor of 5HT-stimulated IP-l accumulation with a Ki value of 12nM, but a selective 5HT-l antagonist, (-)-propranolol(l <micro> M), failed to block the 5HT response. Metergoline, a mixed 5HT-l and 5HT-2 antagonist, caused almost the same reduction in 5HT-stimulated IP-l formation, with a Ki value of 5nM, as ketanserin. These results indicate that 5HT is activating 5HT-2,but not 5HT-l receptors in human platelets. Moreover, chlorpromazine and imipramine inhibited 5HT-stimulated IP-l accumulation, with Ki values of 124nM and 2560nM, respectively. Spiperone(l <micro> M) inhibitedcompletely, and clozapine(l <micro> M) and amitriptyline(l <micro> M) reduced partially(80-50%), 5HT-induced IP-l accumulation; sulpiride(l <micro> M) failed to block the 5HT response. The potencies of these compounds to inhibit 5HT-stimulated IP-l accumulation in human platelets correlates positively with the affinities to 5HT-2 receptors as defined by radioligand binding in rat cerebral cortical membranes. This extends the usefulness of the platelets as a model for 5HT-2 receptors since ligand binding studies can be complemented by measurements of a defined biochemical response.
使用Berridge(1983)的敏感的放射性分析方法在人血小板中研究了肌醇磷脂的代谢,因为众所周知,酮酸盐会拮抗5HT诱导的形状变化和细胞内无基离子的上升。在带有<^3H> -Myo肌醇预先标签的血小板中,在含有10mm LICL和L <micro> M氟西汀的CA离子HEPES缓冲液中,5HT在15 min孵化过程中导致肌醇-l-磷酸(IP)的剂量依赖性依赖性剂量依赖性。在30 <micro> m的5HT时观察到IP-L形成的最大增加,其<ec_(50)>值为4 <micro> M.酮类素,一种选择性的5HT-2拮抗剂,是5HT刺激的IP-L积累的有效抑制剂,具有12nm的Ki值,但是12NM,但选择性5HT-LHT-L抗抗元素(l MICROAL)(l MICROR)(l),<<<<<) - <<<<<) - <<<<<<) - <<<<)阻止5HT响应。元素元(一种混合的5HT-L和5HT-2拮抗剂)与酮蛋白的Ki值为5nm,在5HT刺激的IP-L形成中几乎相同的降低。这些结果表明5HT激活了5HT-2,但在人血小板中没有激活5HT-L受体。此外,氯丙嗪和咪吡金抑制了5HT刺激的IP-L积累,Ki值分别为124nm和2560nm。尖型(L micro> m)抑制了抑制,氯氮平(L micro> m)和阿米替林(L micro> m)部分减少(80-50%),5HT诱导的IP-L积累; Sulpiride(L <micro> m)未能阻止5HT响应。这些化合物抑制人血小板中5HT刺激的IP-L积累的功能与大鼠脑皮质膜中的放射性结合所定义的5HT-2受体的亲和力正相关。这扩展了血小板作为5HT-2受体模型的有用性,因为配体结合研究可以通过定义的生化反应的测量来补充。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masahiko Mikuni: "Advances in the research on the mechanisms of action of antidepressant agents." Japanese J. of Neuropsychopharmacology. 9. 78-92 (1987)
三国正彦:“抗抑郁药作用机制的研究进展。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masahiko Mikuni: "Effects of acute or subchronic administration of antidepressant agents on monoaminergic receptor binding sites in rat cerebral cortex: a comparison with effects of neuroleptics." Japanese J. of Psychopharmacology. 5. 57-58 (1985)
Masahiko Mikuni:“急性或亚慢性服用抗抑郁药对大鼠大脑皮层单胺能受体结合位点的影响:与精神安定药的效果比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIKUNI Masahiko其他文献
MIKUNI Masahiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIKUNI Masahiko', 18)}}的其他基金
Neuropathological studies on the vulnerability to mood disorders and refractoriness to antidepressant treatment.
关于情绪障碍易感性和抗抑郁治疗无效的神经病理学研究。
- 批准号:
14570909 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neuroscientific Investigation of the Pathophysiology of Mood Disorder and Suicide Behavior
情绪障碍和自杀行为病理生理学的神经科学研究
- 批准号:
11470200 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
What kind of neural circuit in the brain of prenatally stressed offspring may be responsible to the vulnerabill to chronic stress in adulthood
产前应激后代大脑中的哪种神经回路可能导致其成年后容易遭受慢性应激
- 批准号:
09670975 - 财政年份:1997
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Strategies for the study of the disinhibition of Hypothalamic-Pituitary-Adrenal axis in affective disorders, using prenatal stress model.
使用产前应激模型研究情感障碍中下丘脑-垂体-肾上腺轴去抑制的策略。
- 批准号:
06670994 - 财政年份:1994
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Molecular Pharmacological Study on the Dysfunction of 5-HT-2 receptor-stimulated Transduction Signaling in Depression.
抑郁症中 5-HT-2 受体刺激转导信号功能障碍的分子药理学研究。
- 批准号:
03454295 - 财政年份:1991
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Hyperresponsiveness of 5-HT-2 Receptor-Mediated Intracellular Camobilization in Platelets from the Depressed Patients and in C6 Glioma Cells Pretreated with Dexamethasone.
抑郁症患者血小板和地塞米松预处理的 C6 胶质瘤细胞中 5-HT-2 受体介导的细胞内固定化的高反应性。
- 批准号:
01570621 - 财政年份:1989
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study on the function of monoamine receptors and transmembrane signal control in the affective disorders.
情感障碍中单胺受体功能和跨膜信号控制的研究。
- 批准号:
62570482 - 财政年份:1987
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Parkinson's Disease Neuroprotection Clinical Centers
帕金森病神经保护临床中心
- 批准号:
7564952 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
Metabolic Engineering of Cancer for Immunotargeting
用于免疫靶向的癌症代谢工程
- 批准号:
7456103 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
MANASSANTIN A, AN ATYPICAL NEUROLEPTIC AGENT
甲纳山汀 A,一种非典型神经阻滞剂
- 批准号:
3375774 - 财政年份:1982
- 资助金额:
$ 1.34万 - 项目类别:
MANASSANTIN A, AN ATYPICAL NEUROLEPTIC AGENT
甲纳山汀 A,一种非典型神经阻滞剂
- 批准号:
3375771 - 财政年份:1982
- 资助金额:
$ 1.34万 - 项目类别:
MANASSANTIN A, AN ATYPICAL NEUROLEPTIC AGENT
甲纳山汀 A,一种非典型神经阻滞剂
- 批准号:
3375773 - 财政年份:1982
- 资助金额:
$ 1.34万 - 项目类别: